Doctor profile · Federal record

Dr. Kenneth Minielly, M.D.

Dermatology Physician (CMS: Dermatology) · Springfield, IL

  • NPI 1699125062
  • Accepts Medicare
  • MIPS 85.8 / 100 · 2023
  • 6 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
751 N Rutledge St Ste 2300
Springfield, IL 627024968
(217) 545-8000
fax (217) 545-7438
Mailing address
Po Box 19644
Springfield, IL 627949644

Credentials & registration

NPPES · NUCC
NPI registered
June 2016 — 10 yrs on file
Year of graduation
2020 — 6 yrs since
Specialty taxonomy
207N00000X — NUCC code
State license (1)
Illinois #125-068691

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1699125062. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
7,706
Distinct HCPCS
10
Medicare allowed
$402,354
HCPCS Description Services Patients Avg allowed
17003 Destruction of precancer skin growth, 2-14 growths 3,225 548 $6
99213 Established patient office or other outpatient visit, 20-29 minutes 1,441 1,035 $83
17000 Destruction of precancer skin growth, 1 growth 926 720 $48
11106 Incision biopsy, first skin growth 471 430 $139
17110 Destruction of skin growth, 1-14 growths 435 353 $89
99203 New patient office or other outpatient visit, 30-44 minutes 266 266 $104
99214 Established patient office or other outpatient visit, 30-39 minutes 248 187 $118
11107 Incision biopsy, each additional skin growth 147 112 $64
17004 Destruction of precancer skin growth, 15 or more growths 106 77 $153
99212 Established patient office or other outpatient visit, 10-19 minutes 101 98 $52

In context: peer comparison

Among 6 peers in this city , average services per provider: 240. This provider delivers 32× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,609
Transactions
68
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Janssen Biotech, Inc. 12 $473.74
ABBVIE INC. 11 $165.97
Novartis Pharmaceuticals Corporation 8 $140.39
Organogenesis Inc. 5 $111.80
Boehringer Ingelheim Pharmaceuticals, Inc. 4 $93.49
Incyte Corporation 4 $93.27
GENZYME CORPORATION 3 $87.06
ConvaTec Inc. 4 $82.63
UCB, Inc. 4 $69.37
Lilly USA, LLC 4 $59.52
Arcutis Biotherapeutics, Inc. 2 $39.31
LEO Pharma Inc. 2 $38.58
Amgen Inc. 2 $30.16
Regeneron Healthcare Solutions, Inc. 1 $29.00
E.R. Squibb & Sons, L.L.C. 2 $27.89

By nature of payment

Food and Beverage
$1,459
Education
$150

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,324
Patients
749
Total drug cost
$1,217,247
Drug Type Claims Patients Total cost
Clobetasol Propionate Generic 255 165 $16,948
Triamcinolone Acetonide Generic 226 143 $3,368
Ketoconazole Generic 213 123 $5,024
Dupixent Pen (Dupilumab) Brand 94 15 $357,932
Mupirocin Generic 83 61 $641
Metronidazole Generic 65 40 $6,733
Methotrexate (Methotrexate Sodium) Brand 63 16 $2,114
Doxycycline Hyclate Generic 57 40 $860
Hydrocortisone Generic 49 37 $341
Fluorouracil Generic 46 41 $6,426

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Kenneth Minielly's medical specialty?
Dr. Kenneth Minielly practices Dermatology Physician in Springfield, IL.
Where does Dr. Kenneth Minielly practice?
Dr. Kenneth Minielly practices at 751 N Rutledge St Ste 2300, Springfield, IL 627024968. Office phone: 2175458000.
What is Dr. Kenneth Minielly's NPI?
Dr. Kenneth Minielly's National Provider Identifier (NPI) is 1699125062, issued by NPPES.
Does Dr. Kenneth Minielly accept Medicare assignment?
Yes. Dr. Kenneth Minielly accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Kenneth Minielly commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.